Oxford Global Training’s Antibody Drug Conjugates course is an intensive 2 day training course looking into the design, development and production of optimal Antibody Drug Conjugates. Delegates will gain an overview of ADC strategies from lab to market, along with a practical understanding of the latest therapeutic applications. Numbers are limited to 20 delegates per course to offer an interactive learning experience with Rajesh Krishnamurthy, a leading expert with first hand experience of ADC successes experience by Zygenia, Immunogen and their large pharma partners. Training will be tailored to each participant’s level of experience and desired outcomes, through a specially designed pre-course questionnaire.
The ADC Training Course enables you to make an immediate impact back in the workplace. The course will focus on the following key skills:
The Antibody Drug Conjugates course will be of most benefit to those with some prior experience in the antibody field, but with limited knowledge of Antibody Drug Conjugates.
For more information please visit: http://www.oxfordglobaltraining.com/about-us/antibody-drug-conjugates/